Avita Therapeutics

2.830

+0.0401.43%

Volume:123.54K

Turnover:346.43K

Market Cap:372.96M

PE:-0.09

High:2.835

Open:2.800

Low:2.790

Close:2.790

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies-0.38%

Capital Flow

Inflow:

Outflow:

News

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AVH.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AVH.AU"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVH.AU\",,,,,undefined,":{"symbol":"AVH.AU","market":"AU","secType":"STK","nameCN":"Avita Therapeutics","latestPrice":2.83,"timestamp":1741148201527,"preClose":2.79,"halted":0,"volume":123535,"delay":0,"changeRate":0.014337,"change":0.04,"floatShares":3227475,"shares":131787710,"eps":-30.555538,"lyrEps":-30.555536,"pbRate":51.86,"amount":346434,"amplitude":0.016129,"volumeRatio":0.830364,"dividePrice":0,"prevYearClose":4.25,"fiveDayClose":3,"twentyDayClose":2.95},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVH.AU\",,,,,undefined,":{"symbol":"AVH.AU","floatShares":3227475,"roa":"-36.97%","roe":"-230.96%","lyrEps":-30.575283,"volumeRatio":0.830364,"shares":131787710,"dividePrice":0,"high":2.835,"amplitude":0.016129,"preClose":2.79,"low":2.79,"week52Low":2.34,"pbRate":"51.83","psRate":"3.63","week52High":5.3,"institutionHeld":0,"latestPrice":2.83,"committee":0.785513,"eps":-30.575282516375154,"divideRate":0,"volume":123535,"delay":0,"ttmEps":-30.575282516375154,"open":2.8,"prevYearClose":4.25,"prevWeekClose":2.85,"prevMonthClose":2.85,"prevQuarterClose":4.25,"fiveDayClose":3,"twentyDayClose":2.95,"sixtyDayClose":4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVH.AU\",params:#limit:5,,,undefined,":[{"date":"2023-08-10","symbol":"AVH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1691625600000,"name":null,"time":"","dateTimestamp":1691589600000,"actualEps":null},{"date":"2023-05-11","symbol":"AVH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1683763200000,"name":null,"time":"","dateTimestamp":1683727200000,"actualEps":null},{"date":"2023-02-23","symbol":"AVH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1677106800000,"name":null,"time":"","dateTimestamp":1677070800000,"actualEps":null},{"date":"2022-11-10","symbol":"AVH.AU","type":"earning","reportTimeType":"post","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1668034800000,"name":null,"time":"Post Market","dateTimestamp":1667998800000,"actualEps":null},{"date":"2022-08-11","symbol":"AVH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1660176000000,"name":null,"time":"","dateTimestamp":1660140000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVH.AU\",market:\"AU\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AVH.AU\",params:#limit:6,delay:false,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":-0.003809}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVH.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2511672246","title":"AVITA Medical Full Year 2024 Earnings: Misses Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2511672246","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511672246?lang=en_us&edition=fundamental","pubTime":"2025-02-15 22:16","pubTimestamp":1739628972,"startTime":"0","endTime":"0","summary":"NasdaqCM:RCEL Earnings and Revenue Growth February 15th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue missed analyst estimates by 2.2%. Earnings per share  also missed analyst estimates by 4.1%.Looking ahead, revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Biotechs industry in the US.The company's shares are up 22% from a week ago.It's still necessary to consider the ever-present spectre of investment risk.   We've identified 1 warning sign  with AVITA Medical, and understanding it should be part of your investment process.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avita-medical-full-2024-earnings-141612158.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RCEL","AVH.AU"],"gpt_icon":0},{"id":"2511695448","title":"AVITA Medical to Host Investor Webinar Briefing","url":"https://stock-news.laohu8.com/highlight/detail?id=2511695448","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511695448?lang=en_us&edition=fundamental","pubTime":"2025-02-14 22:15","pubTimestamp":1739542500,"startTime":"0","endTime":"0","summary":"VALENCIA, Calif., Feb. 14, 2025  -- AVITA Medical, Inc. , a leading therapeutic acute wound care company delivering transformative solutions, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Jim Corbett, Chief Executive Officer, and David O’Toole, Chief Financial Officer, on February 18, 2025, at 2:00 p.m. Pacific Standard Time .About AVITA Medical, Inc.AVITA Medical is a leading therapeutic acute wound care company delivering transformative solutions. Our technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of our platform is the RECELL System, approved by the U.S. Food and Drug Administration for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a groundbreaking solution for improved clinical outcomes at the point-of-care. In the U.S., AVITA Medical ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avita-medical-host-investor-webinar-141500288.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","HST","RCEL","AVH.AU","BK4585","BK4218","BK4588","BK4181"],"gpt_icon":0},{"id":"2511682256","title":"Avita Medical Reports Wider Q4 Loss Despite Higher Revenue; Shares Up 12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511682256","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511682256?lang=en_us&edition=fundamental","pubTime":"2025-02-14 11:40","pubTimestamp":1739504457,"startTime":"0","endTime":"0","summary":"Avita Medical  reported Friday a loss of $0.44 per diluted share in the fourth quarter of 2024, compared with a loss of $0.28 per diluted share in the same period in 2023.Analysts polled by Visible Alpha also expected a loss of $0.44.The dual-listed firm said the wider net loss was due to higher operating expenses and lower other income, net, partially offset by higher gross profit.Total revenue in the quarter ended Dec. 31, 2024, came in at $18.4 million, compared with $14.2 million in the corresponding period in the prior year. Analysts polled by Visible Alpha expected $20.3 million.The company said it expects its full-year 2025 commercial revenue to be in the range of $100 to $106 million, reflecting growth of approximately 55% to 65% over the full-year 2024.The company's shares surged past 12% in recent Friday trade in Australia.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AVH.AU"],"gpt_icon":0},{"id":"2502026876","title":"AVITA Medical, Inc. (RCEL): A Bull Case Theory","url":"https://stock-news.laohu8.com/highlight/detail?id=2502026876","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502026876?lang=en_us&edition=fundamental","pubTime":"2025-01-10 03:04","pubTimestamp":1736449496,"startTime":"0","endTime":"0","summary":"We came across abullish thesison AVITA Medical, Inc.  on Substack by Steve Wagner. In this article, we will summarize the bulls’ thesis on RCEL. AVITA Medical, Inc. 's share was trading at $8.94 as of Jan 8th.A doctor interacting with a patient, discussing the progress of their treatment.Avita Medical  has recently secured FDA approval for its new RECELL GO mini, a disposable cartridge designed specifically for treating smaller wounds up to 480 square centimeters. This innovative product fills a critical gap in the wound care market, particularly for high-volume, smaller wounds typically encountered in trauma and burn centers. Unlike the standard RECELL GO, which is capable of treating wounds up to 1,920 square centimeters, the mini version uses the same multi-use processing device but with an optimized cartridge for smaller skin samples. This adjustment leads to reduced resource consumption and waste, making the product more cost-effective, a key consideration for hospitals facing bud","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avita-medical-inc-rcel-bull-190456504.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QLD","NVIW.SI","BK4139","NQmain",".IXIC","AVH.AU","MNQmain","SQQQ","USJW.SI","RCEL","PSQ","TQQQ","QID","USAW.SI","TSYW.SI"],"gpt_icon":1}],"pageSize":4,"totalPage":9,"pageCount":1,"totalSize":33}]}}